These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 29885197)

  • 61. Women who undergo HPV testing receive earlier detection and treatment of cervical precancers.
    Printz C
    Cancer; 2017 Dec; 123(24):4751. PubMed ID: 29205329
    [No Abstract]   [Full Text] [Related]  

  • 62. [HPV testing and cervix cancer].
    Sørbye S; Fismen S; Gutteberg TJ; Mortensen E
    Tidsskr Nor Laegeforen; 2011 Feb; 131(4):333. PubMed ID: 21339773
    [No Abstract]   [Full Text] [Related]  

  • 63. [Guidelines for HPV screening should be reconsidered].
    Fröberg M; Östensson E; Alder S; Andersson S
    Lakartidningen; 2015 Dec; 112():. PubMed ID: 26625108
    [No Abstract]   [Full Text] [Related]  

  • 64. Cervical cancer: what is the optimal age for routine testing?
    Rob L; Tachezy R; Robova H
    Future Oncol; 2015; 11(8):1137-40. PubMed ID: 25832869
    [No Abstract]   [Full Text] [Related]  

  • 65. Quadrivalent human vaccine - a call to action and for additional research.
    Krogstad P; Cherry JD
    Pediatr Res; 2007 Nov; 62(5):527. PubMed ID: 18049369
    [No Abstract]   [Full Text] [Related]  

  • 66. A report on the current status of European research on the use of human papillomavirus testing for primary cervical cancer screening.
    Davies P; Arbyn M; Dillner J; Kitchener HC; Meijer CJ; Ronco G; Hakama M
    Int J Cancer; 2006 Feb; 118(4):791-6. PubMed ID: 16287075
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cervical cancer: screen regularly: maybe vaccinate.
    Prescrire Int; 2016 Nov; 25(176):269. PubMed ID: 30715826
    [No Abstract]   [Full Text] [Related]  

  • 68. US Food and Drug Administration (FDA) approves stand-alone HPV-DNA testing for cervical cancer screening.
    Mani H
    Natl Med J India; 2014; 27(4):241. PubMed ID: 25668179
    [No Abstract]   [Full Text] [Related]  

  • 69. Cervical cancer screening in developing countries.
    Patra S; Panda D
    Indian J Cancer; 2010; 47(3):344-5. PubMed ID: 20587915
    [No Abstract]   [Full Text] [Related]  

  • 70. Early detection of cervical cancer by human papillomavirus DNA testing: case reports.
    Dunton CJ; Dooley M; Holtz DO
    J Low Genit Tract Dis; 2006 Oct; 10(4):256-7. PubMed ID: 17012993
    [No Abstract]   [Full Text] [Related]  

  • 71. [Cervical cancer: new methods of prevention].
    Petry KU
    Med Monatsschr Pharm; 2004 May; 27(5):152-8; quiz 159-60. PubMed ID: 15171593
    [No Abstract]   [Full Text] [Related]  

  • 72. Gynecological cancer: More evidence supporting human papillomavirus testing.
    Castle PE
    Nat Rev Clin Oncol; 2012 Feb; 9(3):131-2. PubMed ID: 22330684
    [No Abstract]   [Full Text] [Related]  

  • 73. Recommendations for Implementing Human Papillomavirus-Based Cervical Cancer Screening: Lessons Learned from the HPV FOCAL Trial.
    Smith L; van Niekerk D; Coldman A; Krajden M; Franco EL; Ogilvie G
    J Obstet Gynaecol Can; 2016 Aug; 38(8):723-6. PubMed ID: 27638983
    [No Abstract]   [Full Text] [Related]  

  • 74. The changing face of cervical cancer screening in the United States.
    Huh WK
    J Natl Compr Canc Netw; 2010 Dec; 8(12):1329-30. PubMed ID: 21147899
    [No Abstract]   [Full Text] [Related]  

  • 75. Participatory innovation for human papillomavirus screening to accelerate the elimination of cervical cancer.
    Rodriguez NM
    Lancet Glob Health; 2021 May; 9(5):e582-e583. PubMed ID: 33865467
    [No Abstract]   [Full Text] [Related]  

  • 76. Cervical Cancer Screening in Low- and Middle-Income Countries-Reply.
    Geldsetzer P; Lemp JM
    JAMA; 2021 Feb; 325(8):790-791. PubMed ID: 33620399
    [No Abstract]   [Full Text] [Related]  

  • 77. Call to Eliminate Cervical Cancer in the Next Decade with a Focus on Brazil.
    Primo WQSP; Speck NMG; Roteli-Martins CM; Fernandes CE; Silva Filho ALD
    Rev Bras Ginecol Obstet; 2021 Jan; 43(1):1-2. PubMed ID: 33513628
    [No Abstract]   [Full Text] [Related]  

  • 78. Elimination of cervical cancer: ensuring equity.
    Bateson D; Woo YL; Kulkarni J
    Lancet Public Health; 2023 Apr; 8(4):e248-e249. PubMed ID: 36965976
    [No Abstract]   [Full Text] [Related]  

  • 79. Cervical cancer elimination: actions needed in the COVID-19 era.
    Huang J; Wong MCS
    Lancet Glob Health; 2023 Feb; 11(2):e171-e172. PubMed ID: 36528032
    [No Abstract]   [Full Text] [Related]  

  • 80. Overcoming barriers to cervical cancer screening in a developing country like Pakistan.
    Zafar R; Burney A
    J Pak Med Assoc; 2022 Sep; 72(9):1896-1897. PubMed ID: 36281008
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.